Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Weng

Showing results (11-20 of 295) with videos related to

Pageof 30
Sort By:
Journal of Diabetes Investigation|May 21, 2014
Diabetes in China: The challenge nowJianping Weng, Yan Bi
Journal of Diabetes Investigation|May 21, 2014
Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?Xilin Yang, Jianping Weng
Journal of Diabetes|April 5, 2013
Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetesWen Xu, Jianping Weng
Journal of Diabetes|August 16, 2013
Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complicationsJianping Weng, Xilin Yang
Science Bulletin|June 19, 2023
Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosisWeiwei Qin, Jianping Weng
Diabetes Care|January 5, 2022
Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509Jianping Weng, Zhiguang Zhou, Lixin Guo
Science China. Life Sciences|July 6, 2023
Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scopeZekai Wu, Tianru Jin, Jianping Weng
Journal of Diabetes Investigation|July 15, 2022
Hyperglycemia-mediated oocyte TET3 insufficiency predisposes offspring to glucose intoleranceXiumei Wu, Suowen Xu, Jianping Weng
Frontiers in Immunology|July 22, 2022
Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling PathwaySuowen Xu, Tengchuan Jin, Jianping Weng
Hepatology (Baltimore, Md.)|October 16, 2019
ReplyDaizhi Yang, Jinhua Yan, Jianping Weng
Pageof 30

Showing results (11-20 of 295) with videos related to

Sort By:
Pageof 30
Journal of Diabetes Investigation|May 21, 2014
Diabetes in China: The challenge nowJianping Weng, Yan Bi
Journal of Diabetes Investigation|May 21, 2014
Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?Xilin Yang, Jianping Weng
Journal of Diabetes|April 5, 2013
Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetesWen Xu, Jianping Weng
Journal of Diabetes|August 16, 2013
Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complicationsJianping Weng, Xilin Yang
Science Bulletin|June 19, 2023
Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosisWeiwei Qin, Jianping Weng
Diabetes Care|January 5, 2022
Comment on Liu et al. Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes Care 2021;44:2503-2509Jianping Weng, Zhiguang Zhou, Lixin Guo
Science China. Life Sciences|July 6, 2023
Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scopeZekai Wu, Tianru Jin, Jianping Weng
Journal of Diabetes Investigation|July 15, 2022
Hyperglycemia-mediated oocyte TET3 insufficiency predisposes offspring to glucose intoleranceXiumei Wu, Suowen Xu, Jianping Weng
Frontiers in Immunology|July 22, 2022
Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling PathwaySuowen Xu, Tengchuan Jin, Jianping Weng
Hepatology (Baltimore, Md.)|October 16, 2019
ReplyDaizhi Yang, Jinhua Yan, Jianping Weng
Pageof 30